Astrid Schafer - Evolva Holding Head RD

EVE Stock  CHF 0.95  0.05  5.56%   

Insider

Astrid Schafer is Head RD of Evolva Holding SA
Age 50
Phone41 61 485 2000
Webhttps://www.evolva.com

Evolva Holding Management Efficiency

The company has return on total asset (ROA) of (0.1134) % which means that it has lost $0.1134 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3693) %, meaning that it generated substantial loss on money invested by shareholders. Evolva Holding's management efficiency ratios could be used to measure how well Evolva Holding manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 3.57 M in total debt with debt to equity ratio (D/E) of 1.6, which is about average as compared to similar companies. Evolva Holding SA has a current ratio of 4.48, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Evolva Holding until it has trouble settling it off, either with new capital or with free cash flow. So, Evolva Holding's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Evolva Holding SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Evolva to invest in growth at high rates of return. When we think about Evolva Holding's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Stefan WeberNewron Pharmaceuticals SpA
58
Eva KaliasSanthera Pharmaceuticals Holdin
N/A
Marco CaremiNewron Pharmaceuticals SpA
66
Dario EklundSanthera Pharmaceuticals Holdin
55
Ursula EberhardtBasilea Pharmaceutica AG
61
Neville MDSanthera Pharmaceuticals Holdin
N/A
Lutz WevelsiepBasilea Pharmaceutica AG
N/A
Gerrit HauckBasilea Pharmaceutica AG
59
Marc SchraderSanthera Pharmaceuticals Holdin
N/A
Damian HellerBasilea Pharmaceutica AG
57
Oliver StrubSanthera Pharmaceuticals Holdin
60
Shabir MDSanthera Pharmaceuticals Holdin
N/A
Roberto GalliNewron Pharmaceuticals SpA
N/A
David VeitchBasilea Pharmaceutica AG
58
Peer SchroderBasilea Pharmaceutica AG
N/A
Marc MDBasilea Pharmaceutica AG
59
Thomas MeierSanthera Pharmaceuticals Holdin
61
Gnther MetzSanthera Pharmaceuticals Holdin
65
Laurenz KellenbergerBasilea Pharmaceutica AG
56
Ravi AnandNewron Pharmaceuticals SpA
66
Dietrich StberBasilea Pharmaceutica AG
N/A
Evolva Holding SA discovers, develops, and commercializes ingredients for use in food, nutrition, personal healthcare, agriculture, and other sectors in Switzerland, United States, Denmark, and internationally. The company was founded in 2004 and is headquartered in Reinach, Switzerland. EVOLVA N operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 67 people. Evolva Holding SA (EVE) is traded on SIX Swiss Exchange in Switzerland and employs 62 people.

Management Performance

Evolva Holding SA Leadership Team

Elected by the shareholders, the Evolva Holding's board of directors comprises two types of representatives: Evolva Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Evolva. The board's role is to monitor Evolva Holding's management team and ensure that shareholders' interests are well served. Evolva Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Evolva Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
Oliver MBA, Advisor
Anne Vos, Chief Officer
Christian Wichert, Chief Officer
Fabienne Gschwind, Head HR
Thomas CFA, Head Relations
Kaspar Mueller, Head Protection
Gerhard Lobmaier, Chief Officer
Astrid Schafer, Head RD
Philipp Frech, Gen Board
Carsten Daweritz, Chief Officer

Evolva Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Evolva Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolva Holding SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
Note that the Evolva Holding SA information on this page should be used as a complementary analysis to other Evolva Holding's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Evolva Stock analysis

When running Evolva Holding's price analysis, check to measure Evolva Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolva Holding is operating at the current time. Most of Evolva Holding's value examination focuses on studying past and present price action to predict the probability of Evolva Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolva Holding's price. Additionally, you may evaluate how the addition of Evolva Holding to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Please note, there is a significant difference between Evolva Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolva Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolva Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.